Key result
TEER rarely leads to infective endocarditis, requiring heart team discussion across 27 reviewed cases.
Why the study?
Infective endocarditis after transcatheter edge-to-edge repair is a rare occurrence, and no study had previously been conducted on this complication.
What are the characteristics and optimal treatment strategies for infective endocarditis following transcatheter edge-to-edge repair?
Systematic Review (n=27)
What are the characteristics and optimal treatment strategies for infective endocarditis following transcatheter edge-to-edge repair?
Answers are grounded in this paper and cite their sources.
Infective endocarditis is a rare but significant complication after TEER that requires a multidisciplinary heart team approach for optimal management.
Transcatheter edge-to-edge repair (TEER) is used extensively in patients with symptomatic severe mitral regurgitation and high surgical risk. While prosthetic valve endocarditis is well documented, infective endocarditis (IE) after TEER is a rare occurrence. To date, no study has been conducted on this complication. We report the case of an 85-year-old man who developed IE 3 months after undergoing TEER, and we systematically review 26 previously published cases of this complication. Our review findings indicate that discussion within the heart team is essential for the decision-making process and treatment strategy determination.
No takes yet. Share an insight, caveat, or question.
Yokoyama et al. (2023) conducted a systematic review in Infective endocarditis after transcatheter edge-to-edge repair (n=27). Transcatheter edge-to-edge repair (TEER) was evaluated. Transcatheter edge-to-edge repair (TEER) can rarely be complicated by infective endocarditis, with a systematic review of 27 cases indicating heart team discussion is essential for treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: